Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Oral exposure to Phytomonas serpens attenuates thrombocytopenia and leukopenia during acute infection with Trypanosoma cruzi.

da Silva RV, Malvezi AD, Augusto Lda S, Kian D, Tatakihara VL, Yamauchi LM, Yamada-Ogatta SF, Rizzo LV, Schenkman S, Pinge-Filho P.

PLoS One. 2013 Jul 2;8(7):e68299. doi: 10.1371/journal.pone.0068299. Print 2013.

2.

Phytomonas serpens, a tomato parasite, shares antigens with Trypanosoma cruzi that are recognized by human sera and induce protective immunity in mice.

Breganó JW, Picão RC, Graça VK, Menolli RA, Itow Jankevicius S, Pinge Filho P, Jankevicius JV.

FEMS Immunol Med Microbiol. 2003 Dec 5;39(3):257-64.

3.

The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents.

Tribulatti MV, Mucci J, Van Rooijen N, Leguizamón MS, Campetella O.

Infect Immun. 2005 Jan;73(1):201-7.

4.

Protective immunity against Trypanosoma cruzi provided by oral immunization with Phytomonas serpens: role of nitric oxide.

Pinge-Filho P, Peron JP, de Moura TR, Menolli RA, Graça VK, Estevão D, Tadokoro CE, Jankevicius JV, Rizzo LV.

Immunol Lett. 2005 Jan 31;96(2):283-90.

PMID:
15585334
5.

Thymocyte depletion in Trypanosoma cruzi infection is mediated by trans-sialidase-induced apoptosis on nurse cells complex.

Mucci J, Hidalgo A, Mocetti E, Argibay PF, Leguizamon MS, Campetella O.

Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3896-901. Epub 2002 Mar 12.

6.

Trypanosoma cruzi subverts host cell sialylation and may compromise antigen-specific CD8+ T cell responses.

Freire-de-Lima L, Alisson-Silva F, Carvalho ST, Takiya CM, Rodrigues MM, DosReis GA, Mendonça-Previato L, Previato JO, Todeschini AR.

J Biol Chem. 2010 Apr 30;285(18):13388-96. doi: 10.1074/jbc.M109.096305. Epub 2010 Jan 27.

7.

Immune system pathogenesis is prevented by the neutralization of the systemic trans-sialidase from Trypanosoma cruzi during severe infections.

Risso MG, Pitcovsky TA, Caccuri RL, Campetella O, Leguizamón MS.

Parasitology. 2007 Apr;134(Pt 4):503-10. Epub 2006 Dec 14.

PMID:
17166319
10.

The trans-sialidase, the major Trypanosoma cruzi virulence factor: Three decades of studies.

Freire-de-Lima L, Fonseca LM, Oeltmann T, Mendonça-Previato L, Previato JO.

Glycobiology. 2015 Nov;25(11):1142-9. doi: 10.1093/glycob/cwv057. Epub 2015 Jul 29. Review.

PMID:
26224786
11.
12.

Comparison of antibody and protective immune responses against Trypanosoma cruzi infection elicited by immunization with a parasite antigen delivered as naked DNA or recombinant protein.

Pereira-Chioccola VL, Costa F, Ribeirão M, Soares IS, Arena F, Schenkman S, Rodrigues MM.

Parasite Immunol. 1999 Feb;21(2):103-10.

13.

Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells.

Rosenberg CS, Zhang W, Bustamante JM, Tarleton RL.

Infect Immun. 2016 Aug 19;84(9):2627-38. doi: 10.1128/IAI.00241-16. Print 2016 Sep.

14.

Trans-sialidase delivered as a naked DNA vaccine elicits an immunological response similar to a Trypanosoma cruzi infection.

Costa F, Pereira-Chioccola VL, Ribeirão M, Schenkman S, Rodrigues MM.

Braz J Med Biol Res. 1999 Feb;32(2):235-9. Review.

PMID:
10347760
15.

Intranasal vaccinations with the trans-sialidase antigen plus CpG Adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges.

Giddings OK, Eickhoff CS, Sullivan NL, Hoft DF.

Infect Immun. 2010 Mar;78(3):1333-8. doi: 10.1128/IAI.00278-09. Epub 2010 Jan 4.

16.

Trypanosoma cruzi trans-sialidase in complex with a neutralizing antibody: structure/function studies towards the rational design of inhibitors.

Buschiazzo A, Muiá R, Larrieux N, Pitcovsky T, Mucci J, Campetella O.

PLoS Pathog. 2012 Jan;8(1):e1002474. doi: 10.1371/journal.ppat.1002474. Epub 2012 Jan 5.

17.

Sialic Acid Glycobiology Unveils Trypanosoma cruzi Trypomastigote Membrane Physiology.

Lantos AB, Carlevaro G, Araoz B, Ruiz Diaz P, Camara Mde L, Buscaglia CA, Bossi M, Yu H, Chen X, Bertozzi CR, Mucci J, Campetella O.

PLoS Pathog. 2016 Apr 8;12(4):e1005559. doi: 10.1371/journal.ppat.1005559. eCollection 2016 Apr.

18.
19.

Antibodies inhibiting Trypanosoma cruzi trans-sialidase activity in sera from human infections.

Leguizamón MS, Campetella O, Russomando G, Almiron M, Guillen I, Ganzález Cappa SM, Frasch AC.

J Infect Dis. 1994 Dec;170(6):1570-4.

PMID:
7995998
20.

Phytomonas serpens: immunological similarities with the human trypanosomatid pathogens.

Santos AL, d'Avila-Levy CM, Elias CG, Vermelho AB, Branquinha MH.

Microbes Infect. 2007 Jul;9(8):915-21. Epub 2007 Apr 12. Review.

PMID:
17556002

Supplemental Content

Support Center